Study Stopped
too slow patiënts recruitment
Evaluation of the Parietex TM Parastomal No Hole Mesh for Repair of Parastomal Hernias in End-colostomies
PHARAO
1 other identifier
observational
10
1 country
1
Brief Summary
Short Title: PHARAOH study: LAPAROSCOPIC PARASTOMAL HERNIA REPAIR WITH A NO HOLE MESH. Objectives: Evaluation of operative complications, colostomy function, Quality of Life and recurrence rate after laparoscopic repair of parastomal hernias in end-colostomies with a ParietexTM Parastomal No Hole mesh. Principle Investigators: Prof. Dr. Frederik Berrevoet, University Hospital Ghent Dr. Filip Muysoms, AZ Maria Middelares Ghent Patient selection: Adult consecutive patients, men or women, aged above 18, planned for primary elective laparoscopic hernia repair of an end-colostomy. A logbook will be kept of adult patients undergoing a parastomal hernia repair in the participating centers during the study period that are not entered in the study, including the reason for non inclusion. A total of 100 patients will be included during 24 months or until the sample size has been reached. Exclusion criteria: previous repair of a parastomal hernia at the same site, emergency operations, open parastomal hernia repair, parastomal hernias at an ileostomy or an ileal conduit stoma, loop colostomies, patients under the age of 18 years, pregnant women, ASA score 4 or more, no informed consent of the patient, patients unable to complete the stoma Quality of Life assessment. Primary Endpoint: Evolution of Quality of Life with the Stoma-QoL score assessment of patients: preoperatively, at 1 month, 12 months and 24 months postoperatively. Secondary Endpoints: Quality of Life of the patients with the EuraHS QoL score: preoperatively, at 1 month, 12 months and 24 month postoperatively. Recurrence rate at 12 and at 24 months postoperatively evaluated by clinical examination and if available computer tomography. Intra-operative and post-operative complications, post-operative hospital stay, operation time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFirst Submitted
Initial submission to the registry
July 7, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedSeptember 1, 2023
August 1, 2023
2.5 years
July 7, 2021
August 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the QoL with the Stomy-QoL score assessment
Evaluation of the QoL with the Stomy-QoL score assessment of patients preop, at 1 month, 12 months and 24 months postoperatively
24 months
Secondary Outcomes (2)
Recurrence rate
24 months
Peri-operative complications
6 months
Interventions
Laparoscopic Modified Sugarbaker technique for repair of parastomal hernias in end-colostomies
Eligibility Criteria
100 adult patients, men or women, aged above 18, planned for primary elective laparoscopic hernia repair of an end-colostomy.
You may qualify if:
- \- adult patients, planned for primary elective laparoscopic hernia repair of an end-colostomy.
You may not qualify if:
- previous repair of a parastomal hernia at the same site
- emergency operations
- open parastomal hernia repair
- parastomal hernias at an ileostomy or an ileal conduit stoma
- loop colostomies
- patients under the age of 18 years
- pregnant women
- ASA score 4 or more
- no informed consent of the patient
- patients unable to complete the stoma Quality of Life assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ghentlead
- Algemeen Ziekenhuis Maria Middelarescollaborator
- University of Wuerzburgcollaborator
- Universitaire Ziekenhuizen KU Leuvencollaborator
- Bispebjerg Hospitalcollaborator
Study Sites (1)
Ghent University Hospital
Ghent, East Flanders, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frederik Berrevoet, MD, PhD
University Ghent
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2021
First Posted
July 19, 2021
Study Start
March 14, 2016
Primary Completion
September 24, 2018
Study Completion
December 31, 2018
Last Updated
September 1, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share